Issue 4, 2022

Evaluation of injectable nucleus augmentation materials for the treatment of intervertebral disc degeneration

Abstract

Back pain affects a person's health and mobility as well as being associated with large health and social costs. Lower back pain is frequently caused by degeneration of the intervertebral disc. Current operative and non-operative treatments are often ineffective and expensive. Nucleus augmentation is designed to be a minimally invasive method of restoring the disc to its native healthy state by restoring the disc height, and mechanical and/or biological properties. The majority of the candidate materials for nucleus augmentation are injectable hydrogels. In this review, we examine the materials that are currently under investigation for nucleus augmentation, and compare their ability to meet the design requirements for this application. Specifically, the delivery of the material into the disc, the mechanical properties of the material and the biological compatibility are examined. Recommendations for future testing are also made.

Graphical abstract: Evaluation of injectable nucleus augmentation materials for the treatment of intervertebral disc degeneration

Article information

Article type
Review Article
Submitted
12 Oct 2021
Accepted
08 Dec 2021
First published
17 Dec 2021
This article is Open Access
Creative Commons BY license

Biomater. Sci., 2022,10, 874-891

Evaluation of injectable nucleus augmentation materials for the treatment of intervertebral disc degeneration

M. P. Culbert, J. P. Warren, A. R. Dixon, H. L. Fermor, P. A. Beales and R. K. Wilcox, Biomater. Sci., 2022, 10, 874 DOI: 10.1039/D1BM01589C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements